List of CycLex Co., Ltd. Publication

 

1. Shimazaki, T., Okazawa, H., Fujii, H., Ikeda, M., Tamai, K., McKey, R. D.G., Muramatsu, M. and Hamada, H.;  Hybrid cell extinction and re-expression of Oct-3 function correlates with differentiation potential

EMBO J 12, 4489-4498, 1993

 

2. Roy, N., Mahadevan, M. S., McLean, M., Shutler, G., Yaragi, Z., Farahani, R., Baird, S., Besner-Johnston, A., Lefebvre, C., Kang, X., Salih, M., Aubry, H., Tamai, K., Guan, X., Ioannou, P., Crawford, T. O., de Jong, P. J., Surh, L., Ikeda, J.-E.,  Korneluk, R. G. and MacKenzie, A.;  

The gene for Neuronal Apoptosis Inhibitory Protein is partially deleted in individuals with Spinal Muscular Atrophy.  

Cell 80, 167-178, 1995

 

3. Liston, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton-Horvat, G., Farahani, R., Mclean, M., Ikeda, J.-E., Mackenzie, A. and Korneluk, R. G.;  Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes.   

Nature 379, 349-353, 1996

 

4. Kitagawa, M., Higashi, H., Jung, H., Suzuki-Takahashi, I., Ikeda, M., Tamai, K., Kato, J., Segawa, K., Yoshida, E., Nishimura, S., Taya, Y.;  The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2

EMBO J. 15: 7060-7069, 1996

 

5. Xu DG, Crocker SJ, Doucet JP, St-Jean M, Tamai K, Hakim AM, Ikeda J-E, Liston P, Thompson CS, Korneluk RG, MacKenzie A, Robertson GS.;  Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus.   

Nature Medicine 3: 997-1004, 1997

 

6. Ko L.J., Chen X., Shieh S-Y., Jayaraman L., Tamai K., Taya Y., Prives C. and Pan Z-Q;

p53 is phosphorylated by CDK7/cyclin H in a p36/MAT1

Mol. Cell. Biol. 17, 7220-7229, 1997

 

7. Mizuno T, Ito N, Yokoi M, Kobayashi A, Tamai K, Miyazawa H, Hanaoka F;  The second-largest subunit of the mouse DNA polymerase alpha-primase complex facilitates both production and nuclear translocation of the catalytic subunit of DNA polymerase alpha.

Mol Cell Biol. 18, 3552-3562, 1998

 

8. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD ;  Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53.

Science 281, 1677-1679, 1998

 

9. Kyoko Yamaguchi, Shin-ichi Nagai, Jun Ninomiya-Tsuji, Michiru Nishita, Katsuyuki Tamai, Kenji Irie, Naoto Ueno, Eisuke Nishida, Hiroshi Shibuya and Kunihiro Matsumoto;  XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway.

EMBO J. 18, 179-187, 1999

 

10. Nakagawa K, Taya Y, Tamai K, Yamaizumi M;  Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks.

Mol Cell Biol 19: 2828-34, 1999

 

11. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y.;  p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.

Cell. 102: 849-62, 2000

 

12. Sheau-Yann Shieh, Jinwoo Ahn, Katsuyuki Tamai, Yoichi Taya, and Carol Prives;  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites

Genes & Dev., 14: 289-300, 2000

 

13. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ.;  Chk1 is an essential kinase that is regulated by atr and required for the G(2)/M DNA damage checkpoint. 

Genes Dev. 14:1448-59, 2000

 

14. Rosalie Sears, Faison Nuckolls, Eric Haura, Yoichi Taya, Katsuyuki Tamai, and Joseph R. Nevins;  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability

Genes & Dev., 14: 2501, 2000

 

 

15. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ; Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. 

Proc Natl Acad Sci U S A. 97: 10389-94, 2000

 

16. Luc A. Sabourin, Katsuyuki Tamai, Patrick Seale, Julian Wagner, and Michael A. Rudnicki;  Caspase 3 Cleavage of the Ste20-Related Kinase SLK Releases and Activates an Apoptosis-Inducing Kinase Domain and an Actin-Disassembling Region

Mol. Cell. Biol., 20: 684-696, 2000

 

17. Tomita A, Towatari M, Tsuzuki S, Hayakawa F, Kosugi H, Tamai K, Miyazaki T, Kinoshita T, Saito H;  c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional　co-activator p300. 

Oncogene, 19: 444-51, 2000

 

18. F. ESASHI, S. MOCHIDA, T. MATSUSAKA, T. OBARA, A. OGAWA, K. TAMAI, AND M. YANAGIDA;  Establishment of and Recovery from Damage Checkpoint Requires Sequential Interactions of Crb2 with Protein Kinases Rad3, Chk1, and Cdc2 

Cold Spring Harbor Symposia on Quantitative Biology Symposium 65, Pages 443-450, 2000

 

19. Liston P, Fong WG, Kelly NK, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW and Korneluk RG;  Identification of XAF1 as an antagonist of XIAP anti-Caspase activity.

Nature Cell Biology, 3, 128-133, 2001

 

20. Shimazaki N, Yoshida K, Kobayashi T, Toji S, Tamai K, Koiwai O.;  Over-expression of human DNA polymerase lambda in E. coli and characterization of the recombinant enzyme.

Genes Cells, 7: 639-651, 2002

 

21. Suzuki S, Tamai K, Yoshida S.;  Enzyme-Linked Immunosorbent Assay for Distinct Cyclin-Dependent Kinase Activities Using Phosphorylation-Site-Specific Anti-pRB Monoclonal Antibodies.

Anal Biochem., 301: 65-74, 2002

 

22. Tanaka M, Tanaka T, Matsuzaki S, Seto Y, Matsuda T, Komori K, Itoh J, Kijima H, Tamai K, Shibayama M, Hashimoto Y, Nakazawa H, Toma H.;  Rapid and quantitative detection of human septin family Bradeion as a practical diagnostic method of colorectal and urologic cancers.

Med Sci Monit. 7: MT61-8, 2003

 

23. Taya Y, Nakajima K, Yoshizawa-Kumagaye, K and Tamai K;  Generation and Application of Phospho-specific Antibodies for p53 and pRB;

Mehtods in Molecular Biology Vol. 223, 17-26, 2003: Tumor Suppressor Genes: Regulation and Function, and Medical Applications

 

24. Itakura E, Takai KK, Umeda K, Kimura M, Ohsumi M, Tamai K, Matsuura A.;  Amino-terminal domain of ATRIP contributes to intranuclear relocation of the ATR-ATRIP complex following DNA damage. 

FEBS Lett. 577: 289-93, 2004

 

25. Mochida S, Esashi F, Aono N, Tamai K, O'Connell MJ, Yanagida M.;  Regulation of checkpoint kinases through dynamic interaction with Crb2. 

EMBO J. 23: 418-28, 2004

 

26. Makoto T. Kimura, Takahiro Mori, Jeffrey Conroy, Norma J. Nowak, Susumu Satomi, Katsuyuki Tamai, and Hiroki Nagase;  Two Functional Coding Single Nucleotide Polymorphisms in STK15 (Aurora-A) Coordinately Increase Esophageal Cancer Risk

Cancer Res., 65: 3548 – 3554, 2005

 

27. Noriko Shimazaki, Takaya Yazaki, Takashi Kubota, Asami Sato, Ayako Nakamura, Shunsuke Kurei, Shingo Toji, Katsuyuki Tamai, and Osamu Koiwai  DNA polymerase lambda directly binds to proliferating cell nuclear antigen through its confined C-terminal region

Genes Cells., 10: 705 – 715, 2005

 

28. Makoto T. Kimura, Norma J. Nowak, Takahiro Mori, Katsuyuki Tamai, and Hiroki Nagase;  Two functional coding single nucleotide polymorphisms in STK15 (Aurora-A) co-ordinately increase esophageal cancer risk

AACR Meeting Abstracts: Apr 2005; 2005: 767.

 

29. Kanoh Y, Tamai K, Shirahige K.;  Different requirements for the association of ATR-ATRIP and 9-1-1 to the stalled replication forks.

Gene. 377: 88-95, 2006

 

30. Yabuta N, Onda H, Watanabe M, Yoshioka N, Nagamori I, Funatsu T, Toji S, Tamai K, Nojima H.; Isolation and characterization of the TIGA genes, whose transcripts are induced by growth arrest.

Nucleic Acids Res. 2006 Sep 14.

 

総説

 

「p53のリン酸化、アセチル化研究の幕開け」

宮崎敏昭、玉井克之

実験医学増刊 細胞周期と癌-p53, RB, チェックポイント制御の新展開　(p72-78)

羊土社、1999 年3月

 

「癌とゲノム創薬」

玉井克之

「ゲノム創薬の最前線」(p68-99) 野島博編集　羊土社、2002年1月